Adult brain cancer in the U.S. black population: A surveillance, epidemiology, and end results (SEER) analysis of incidence, survival, and trends

Medical Science Monitor

Volumn 20, Issue , 2014, Pages 1510-1517

  Gabriel, Abigail ^a,b   Batey, Jason ^a   Capogreco, Joseph ^a   Kimball, David ^a   Walters, Andy ^a   Shane Tubbs, R ^c   Loukas, Marios ^a,d  

^a ST GEORGE S UNIVERSITY SCHOOL OF MEDICINE   (Grenada)

^b HARLEM HOSPITAL CENTER   (United States)

^c BIRMINGHAM CHILDREN S HOSPITAL   (United Kingdom)

^d Medical School Varmia and Mazuria   (Poland)

Author keywords

African Americans; Brain Neoplasms; Epidemiology

Indexed keywords

ADULT; AGED; ARTICLE; ASTROCYTOMA; BRAIN CANCER; CANCER DIAGNOSIS; CANCER EPIDEMIOLOGY; CANCER INCIDENCE; CANCER SURVIVAL; FEMALE; GLIOBLASTOMA; HISTOLOGY; HUMAN; KAPLAN MEIER METHOD; LYMPHOMA; MAJOR CLINICAL STUDY; MALE; MALIGNANT MENINGIOMA; MIDDLE AGED; POPULATION DYNAMICS; RACE DIFFERENCE; RETROSPECTIVE STUDY; SEX DIFFERENCE; VERY ELDERLY; YOUNG ADULT; ADOLESCENT; AFRICAN AMERICAN; AGE; BRAIN NEOPLASMS; CANCER REGISTRY; INCIDENCE; PROPORTIONAL HAZARDS MODEL; STATISTICS AND NUMERICAL DATA; UNITED STATES;

ADOLESCENT; ADULT; AFRICAN AMERICANS; AGE FACTORS; AGED; AGED, 80 AND OVER; BRAIN NEOPLASMS; FEMALE; HUMANS; INCIDENCE; KAPLAN-MEIER ESTIMATE; MALE; MIDDLE AGED; PROPORTIONAL HAZARDS MODELS; SEER PROGRAM; UNITED STATES; YOUNG ADULT;

EID: 84907349842     PISSN: 12341010     EISSN: 16433750     Source Type: Journal    
DOI: 10.12659/MSM.890762     Document Type: Article

References (43)

1. Freedman J: Brain Cancer: Current and Emerging Trends in Detection and Treatment. The Rosen Publishing Group, 2009
2. Deorah S, Lynch C, Sibenaller Z, Ryken T: Trends in brain cancer incidence and survival in the United States: Surveillance, Epidemiology, and End Results Program, 1972 to 2001. Neurosurg Focus, 2006; 20: 1-7
3. Johannesen TB, Angell-Anderson E, Tretli S et al: Trens in incidence of brain and central nervous system tumors in Norway, 1970-1999. Neuroepidemiology, 2004; 23(3): 101-9
4. Legler JM, Ries LAG, Smith MA et al: Cancer surveillance series [corrected]: brain and other central nervous system cancers: recent trends in incidence and mortality. J Natl Cancer Inst, 1999; 91(16): 1382-90
5. McKinley BP, Michalek AM, Fenstermaker RA, Plunkett RJ: The impact of age and sex on the incidence of glial tumors in New York state from 1976 to 1995. J Neurosurg, 2000; 93(6): 932-39
6. Modan B, Wagener DK, Feldman JJ et al: Increased Mortality from Brain Tumors: A Combined Outcome of Diagnostic Technology and Change of Attitude toward the Elderly. Am J Epidemiol, 1992; 135(12): 1349-57
7. Polednak AP: Re: "Increased mortality from brain tumors: a combined outcome of diagnostic technology and change of attitude toward the elderly. " Am J Epidemiol, 1994; 140: 1138-43
8. Mariotto AB, Yabroff KR, Shao Y et al: Projections of the Cost of Cancer Care in the United States: 2010-2020. J Natl Cancer Inst, 2010; 103(2): 117-28
9. Kohler BA, Ward E, McCarthy BJ et al: Annual Report to the Nation on the Status of Cancer, 1975-2007, Featuring Tumors of the Brain and Other Nervous System. J Natl Cancer Inst, 2011; 103(9): 714-36
10. Inskip PD, Hoover RN, Devesa SS: Brain cancer incidence trends in relation to cellular telephone use in the United States. Neurooncology, 2010; 12(11): 1147-51
11. Siegel R, Naishadham D, Jemal A: Cancer statistics, 2013. Cancer J Clin, 2013; 63(1): 11-30
12. Barnholtz-Sloan JS, Sloan AE, Schwartz AG: Racial Differences in Survival after Diagnosis with Primary Malignant Brain Tumor. Cancer, 2003; 98(3): 603-9
13. Central Brain Tumor Registry of the United States (CBTRUS). CBTRUS Statistical Report: Primary Brain and Central Nervous System Tumors Diagnosed in the United States 2004-2007. Hinsdale, IL: Central Brain Tumor Registry of the United States; Feb 2011
14. Egan KM, Thompson RC, Nabors LB et al: Cancer susceptibility variants and the risk of adult glioma in the US case-control study. J Neurooncol, 2011; 104(2): 535-42
15. Sima X, Xu J, Li Q et al: Gene-Gene Interactions Between Interleukin-12A and Interleukin-12B with the Risk of Brain Tumor. DNA Cell Biol, 2012; 31(2): 219-23
16. Xu C, Yuan L, Tian H et al: Association of the MTHFR C677T polymorphism with primary brain tumor risk. Tumor Biol, 2013; 34(6): 3457-64
17. van den Bent MJ, Gravendeel LA, Gorlia T et al: A Hypermethylated Phenotype is a Better Predictor of Survival than MGMT Methylation in Anaplastic Oligodendroglial Brain Tumors: A Report from EORTC Study 26951. Clin Cancer Res, 2011; 17(22): 7148-55
18. Wang X, Chen J, Liu J et al: Gain of Function of Mutant TP53 in Glioblastoma: Prognosis and Response to Temozolomide. Ann Surg Oncol, 2014; 21(4): 1337-44
19. Melin B, Jenkins R: Genetics in glioma: lessons learned from genome-wide association studies. Curr Opin Neurol, 2013; 26(6): 687-92
20. Zhang F, Li D, Li Y et al: Quantitative assessment of the association between TP53 Arg72Pro polymorphism and risk of glioma. Tumor Biol, 2014; 35: 747-51
21. Legler J, Gloeckler Ries L, Smith M et al: Brain and Other Central Nervous System Cancers: Recent trens in Incidence and Mortality. J Natl Cancer Inst, 1999; 91(16): 1382-90
22. Curry W, Barker F: Racial, ethnic and socioeconomic disparities in the treatment of brain tumors. J Neurooncol, 2009; 93: 25-39
23. Bishop A, McDonald M, Chang A, Esiashvili N: Infant Brain Tumors: Incidence, Survival, and the Role of Radiation Based on Surveillance, Epidemiology, and End Results (SEER) Data. Int J Radiat Oncol Biol Phys, 2012; 82(1): 341-47
24. Kadan-Lottick N, Skluzacek M, Gurney J: Decreasing Incidence Rates of Primary Central Nervous System Lymphoma. Cancer, 2002; 95(1): 193-202
25. SEER Program Coding and Staging Manual 2011. Surveillance Systems Branch, Surveillance Research Program, Division of Cancer and Population Sciences, National Institutes ofHeath, Public Health Service, US Department of Health and Human Services. Effective Date: Cases Diagnosed January 1, 2011. NIH Publication Number 11-5581. http://seer.cancer.gov/manuals/2011/SPCSM_2011_maindoc_09272011.pdf
26. Adamson C, Kanu O, Mehta A et al: Glioblastoma multiforme: a review of where we have been and where we are going. Expert Opin Investig Drugs, 2009; 18(8): 1061-83
27. Tatter S: "The new WHO Classification of tumoros affecting the Central Nervous System" 2006 http://neurosurgery.mgh.harvard.edu/newwhobt. htm
28. Villano JL, Koshy M, Shaikh H et al: Age, gender, and racial differences in incidence and survival in primary CNS lymphoma. Br J Cancer, 2011; 105(9): 1414-18
29. Smith M, Freidlin B, Gloeckler Ries L, Simon R: Trends in Reported Incidence of Primary Malignant Brain Tumors in Children in the United States. J Nat Cancer Inst, 1998; 90(17): 1269-77
30. Cote TR, Manns A, Hardy CR et al: Epidemiology of brain lymphoma among people with or without acquired immunodeficiency syndrome. AIDS/Cancer Study Group. J Natl Cancer Inst, 1996; 88: 657-79
31. Morris M, Hancock MS, Miller WC et al: Prevalence of HIV infection among young adults in the United States: results from the Add Health Study. Am J Public Health, 2006; 96: 1091-97
32. Birkmeyer JD, Siewers AE, Finlayson EV et al: Hospital volume and surgical mortality in the United States. N Engl J Med, 2002; 346: 1128-37
33. Brach PB, Schrag D, Brawley OW et al: Survival of Blacks and Whites After a Cancer Diagnosis. JAMA, 2002; 287(16): 2106-13
34. Sigrid H, Alofs L, Huiskes J, Wijnen-Meijer: Ordering patterns for laboratory and radiology tests by students from different undergraduate medical curricula. BMC Med Educ, 2013; 13: 109
35. Owlia M, Deible C, Hughes MA et al: Head CT scan overuse in frequently admitted medical patients. Am J Med, 2014; 127(5): 406-10
36. Stern R: "Can we all get along?" Cooperative strategies to reduce imaging overuse. Am J Med, 2013; 126(8): 657-58
37. Braganza MZ, Kitahara CM, Berrington de Gonzalez A et al: Ionizing radiation and the risk of brain and central nervous system tumors: a systematic review. Neuro Oncol, 2012; 14(11): 1316-24
38. Kitahara CM, Linet MS, Brenner AV et al: Personal History of Diabetes, Genetic Susceptibility to Diabetes, and Risk of Brain Glioma: A Pooled Analysis of Observational Studies. Cancer Epidemiol Biomarkers Prev, 2014; 23(1): 47-54
39. Sorensen AG, Emblem KE, Polaskova P et al: Increased Survival of Glioblastoma Patients Who Respond to Antiangiogenic Therapy with Elevated Blood Perfusion. Cancer Res, 2012; 72(2): 402-7
40. DeAngelis LM: Anaplastic Glioma: How to Prognosticate Outcome and Choose a Treatment Strategy. J Clin Oncol, 2009; 27(25): 5861-62
41. Ponzoni M, Issa S, Batchelor TT, Rubenstein JL: Beyond high-dose methotrexate and brain radiotherapy: novel targets and agents for primary CNS lymphoma. Ann Oncol, 2014; 25(2): 316-22
42. Rosenstock S, Whitman S, West JF, Balkin M: Racial Disparities in Diabetes Mortality in the 50 Most Populous US Cities. J Urban Health, 2014 [Epub ahead of print]
43. Ali AN, Travers K, Athavale N, Al-Modoaris F: Malignant meningioma-a rare cause of temporal head lump. QJM, 2012 [Epub ahead of print]